Search Within

Marie Brevet

Formats
  1. Meeting Abstract (7)
  2. Journal Article (4)
Groups
  1. Department of Pathology and Laboratory Medicine (11)
  2. GSK Faculty (11)
  3. Human Oncology and Pathogenesis Program (11)
  4. Tow Center for Developmental Oncology (TCDO) (11)
  5. Surgery (6)
  6. Sloan Kettering Institute Postdocs (2)

More Groups

People
  1. Marc Ladanyi (11)
  2. Qin Zhou (6)
  3. Valerie Rusch (6)
  4. Matthew Bott (5)
  5. Maureen Zakowski (5)
  6. Adam Olshen (4)

More People

Years
  1. 2011 (5)
  2. 2010 (5)
  3. 2009 (1)
Publications
  1. Journal of Clinical Oncology (2)
  2. Journal of Molecular Diagnostics (2)
  3. Laboratory Investigation (2)
  4. Modern Pathology (2)
  5. Journal of Thoracic Oncology (1)
  6. Lung Cancer (1)

More Publications

Publishers
  1. Nature Publishing Group (3)
  2. American Society of Clinical Oncology (2)
  3. Elsevier Science, Inc. (2)
  4. Nature Research (2)
  5. Elsevier Inc. (1)
  6. Elsevier Ireland Ltd. (1)

Results (11)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Association of NF2 loss and MTOR pathway activation in pleural mesothelioma: Comprehensive genetic analysis of NF2 and immunohistochemistry in 13 cell lines and 53 tumors
    Meeting Abstract

    Brevet, M.; Bott, M.; Zhou, Q.; Rusch, V.; Ladanyi, M.
    Modern Pathology (2011)

    Fulltext@MSK | Save
  • Association of NF2 loss and MTOR pathway activation in pleural mesothelioma: Comprehensive genetic analysis of NF2 and immunohistochemistry in 13 cell lines and 53 tumors
    Meeting Abstract

    Brevet, M.; Bott, M.; Zhou, Q.; Rusch, V.; Ladanyi, M.
    Laboratory Investigation (2011)

    Fulltext@MSK | Save
  • The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma
    Journal Article

    Bott, M.; Brevet, M.; Taylor, B. S.; Shimizu, S.; Ito, T.; Wang, L.; Creaney, J.; Lake, R. A.; Zakowski, M. F.; Reva, B.; more...
    Nature Genetics (2011)

    Fulltext@MSK | Save
  • Coactivation of receptor tyrosine kinases in malignant mesothelioma as a rationale for combination targeted therapy
    Journal Article

    Brevet, M.; Shimizu, S.; Bott, M. J.; Shukla, N.; Zhou, Q.; Olshen, A. B.; Rusch, V.; Ladanyi, M.
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save
  • Detection of EGFR mutations in plasma DNA from lung cancer patients by mass spectrometry genotyping is predictive of tumor EGFR status and response to EGFR inhibitors
    Journal Article

    Brevet, M.; Johnson, M. L.; Azzoli, C. G.; Ladanyi, M.
    Lung Cancer (2011)

    Fulltext@MSK | Save
  • Use of integrated genomic analysis to evaluate BRCA-associated protein 1 (BAP1) as a mutated gene in malignant pleural mesothelioma (MPM)
    Meeting Abstract

    Bott, M. J.; Brevet, M.; Taylor, B. S.; Shimizu, S.; Ito, T.; Zhou, Q.; Olshen, A.; Zakowski, M. F.; Rusch, V. W.; Ladanyi, M.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Effect of EGFR and IGF1R on feedback activation of AKT arising from inhibition of mTOR in malignant pleural mesothelioma (MPM)
    Meeting Abstract

    Brevet, M.; Shimizu, S.; Zhou, Q.; Olshen, A.; Zakowski, M. F.; Rusch, V. W.; Ladanyi, M.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Assessment of EGFR mutation status in needle biopsies and cytology specimens of lung adenocarcinoma by immunohistochemistry using antibodies to the two major forms of mutant EGFR
    Meeting Abstract

    Ang, D. C.; Brevet, M.; Ladanyi, M.; Zakowski, M. F.
    Laboratory Investigation (2010)

    Fulltext@MSK | Save
  • Assessment of EGFR mutation status in needle biopsies and cytology specimens of lung adenocarcinoma by immunohistochemistry using antibodies to the two major forms of mutant EGFR
    Meeting Abstract

    Ang, D. C.; Brevet, M.; Ladanyi, M.; Zakowski, M. F.
    Modern Pathology (2010)

    Fulltext@MSK | Save
  • Assessment of EGFR mutation status in lung adenocarcinoma by immunohistochemistry using antibodies specific to the two major forms of mutant EGFR
    Journal Article

    Brevet, M.; Arcila, M.; Ladanyi, M.
    Journal of Molecular Diagnostics (2010)

    Fulltext@MSK | Save